Assessing Adhesion With Transdermal and Topical Delivery Systems for ANDAs Draft Guidance for Industry
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
April 12, 2023
April 14, 2023
2987a560-17ed-4e62-b674-1c17e17f5298
Related Documents
Topical Dermatologic Corticosteroids: In Vivo Bioequivalence
Guidance DocumentOctober 24, 2023Center for Drug Evaluation and Research
Assessment of Adhesion for Topical and Transdermal Systems Submitted in New Drug Applications : Draft Guidance for Industry
Guidance DocumentJuly 1, 2021Center for Drug Evaluation and Research
Assessing the Irritation and Sensitization Potential of Transdermal and Topical Delivery Systems for ANDAs: Draft Guidance for Industry
Guidance DocumentApril 13, 2023Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox